Brian T Crum is SVP, General Counsel & Secr. of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 177,497 shares of LXRX, which is worth approximately $147,322. The most recent transaction as insider was on Feb 28, 2024, when has been sold 25,604 shares (Common Stock) at a price of $2.62 per share, resulting in proceeds of $67,082. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 177K
0% 3M change
31.68% 12M change
Total Value Held $147,322

Brian T Crum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 28 2024
SELL
Payment of exercise price or tax liability
$67,082 $2.62 p/Share
25,604 Reduced 12.61%
177,497 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
68,303 Added 25.17%
203,101 Common Stock
Feb 28 2023
SELL
Payment of exercise price or tax liability
$44,565 $2.17 p/Share
20,537 Reduced 13.22%
134,798 Common Stock
Feb 28 2023
BUY
Exercise of conversion of derivative security
-
55,877 Added 26.46%
155,335 Common Stock
Feb 28 2022
SELL
Payment of exercise price or tax liability
$42,918 $2.85 p/Share
15,059 Reduced 13.15%
99,458 Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
40,880 Added 26.31%
114,517 Common Stock
Feb 28 2021
SELL
Payment of exercise price or tax liability
$106,843 $7.19 p/Share
14,860 Reduced 16.79%
73,637 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
38,765 Added 30.46%
88,497 Common Stock
BTC

Brian T Crum

SVP, General Counsel & Secr.
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX